Koers Bud Genius, Inc. Other OTC
Aandelen
RIGH
US76657X1110
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | 0,04 0,04 | Marktkapitalisatie | 11,25K 10,51K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | - 0 | Nettowinst (verlies) 2010 | - 0 | EV/omzet 2009 | - |
Nettoschuld 2009 | 489K 457K | Nettoschuld 2010 | 396K 370K | EV/omzet 2010 | 9.639.795 x |
K/w-verhouding 2009 |
-23,5
x | K/w-verhouding 2010 |
-
| Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 690,57% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,36% | 52,5 mld. | |
+36,73% | 39,31 mld. | |
-8,63% | 39,01 mld. | |
+25,46% | 28,2 mld. | |
-11,17% | 26,57 mld. | |
+11,44% | 26,2 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,62 mld. | |
-5,30% | 11,74 mld. |